A detailed history of Arjuna Capital transactions in Sanofi stock. As of the latest transaction made, Arjuna Capital holds 38,952 shares of SNY stock, worth $1.9 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
38,952
Holding current value
$1.9 Million
% of portfolio
0.6%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$48.54 - $58.53 $1.89 Million - $2.28 Million
38,952 New
38,952 $2.25 Million
Q4 2023

Feb 08, 2024

BUY
$43.13 - $54.79 $79,488 - $100,977
1,843 Added 13.76%
15,234 $757,000
Q3 2023

Nov 09, 2023

BUY
$50.95 - $55.2 $21,246 - $23,018
417 Added 3.21%
13,391 $718,000
Q2 2023

Aug 09, 2023

BUY
$50.45 - $57.18 $28,252 - $32,020
560 Added 4.51%
12,974 $699,000
Q1 2023

May 15, 2023

SELL
$45.86 - $54.45 $116,025 - $137,758
-2,530 Reduced 16.93%
12,414 $675,000
Q4 2022

Feb 06, 2023

BUY
$38.86 - $48.55 $38,082 - $47,579
980 Added 7.02%
14,944 $723,000
Q3 2022

Nov 01, 2022

BUY
$37.22 - $100.5 $55,048 - $148,639
1,479 Added 11.85%
13,964 $531,000
Q2 2022

Jul 22, 2022

SELL
$48.99 - $57.46 $489 - $574
-10 Reduced 0.08%
12,485 $625,000
Q1 2022

May 12, 2022

BUY
$48.48 - $53.65 $137,198 - $151,829
2,830 Added 29.28%
12,495 $641,000
Q4 2021

Feb 11, 2022

BUY
$47.07 - $52.35 $96,352 - $107,160
2,047 Added 26.87%
9,665 $484,000
Q3 2021

Nov 08, 2021

BUY
$47.89 - $53.12 $53,349 - $59,175
1,114 Added 17.13%
7,618 $367,000
Q2 2021

Aug 11, 2021

BUY
$49.36 - $54.25 $100,052 - $109,964
2,027 Added 45.28%
6,504 $343,000
Q1 2021

May 11, 2021

SELL
$45.46 - $50.51 $2.11 Million - $2.35 Million
-46,465 Reduced 91.21%
4,477 $221,000
Q4 2020

Feb 09, 2021

BUY
$45.3 - $51.62 $2.31 Million - $2.63 Million
50,942 New
50,942 $2.48 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $122B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Arjuna Capital Portfolio

Follow Arjuna Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arjuna Capital, based on Form 13F filings with the SEC.

News

Stay updated on Arjuna Capital with notifications on news.